Tissue Plasminogen Activator Is Not Involved in Methamphetamine-Induced Neurotoxicity

To investigate the role of tissue plasminogen activator (tPA) in methamphetamine (METH)-induced dopaminergic neurotoxicity, we compared the changes in tyrosine hydroxylase (TH) and dopamine transporter (DAT) levels in the striatum after repetitive treatment of METH at 4 mg/kg among wild-type, tPA-de...

Full description

Saved in:
Bibliographic Details
Main Authors: Ayumi Fukakusa (Author), Hiroyuki Mizoguchi (Author), Hiroyuki Koike (Author), Toshitaka Nabeshima (Author), Kazuhiro Takuma (Author), Kiyofumi Yamada (Author)
Format: Book
Published: Elsevier, 2008-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_abd51f5e1b8c4e788cf5586c88627e02
042 |a dc 
100 1 0 |a Ayumi Fukakusa  |e author 
700 1 0 |a Hiroyuki Mizoguchi  |e author 
700 1 0 |a Hiroyuki Koike  |e author 
700 1 0 |a Toshitaka Nabeshima  |e author 
700 1 0 |a Kazuhiro Takuma  |e author 
700 1 0 |a Kiyofumi Yamada  |e author 
245 0 0 |a Tissue Plasminogen Activator Is Not Involved in Methamphetamine-Induced Neurotoxicity 
260 |b Elsevier,   |c 2008-01-01T00:00:00Z. 
500 |a 1347-8613 
500 |a 10.1254/jphs.SC0070328 
520 |a To investigate the role of tissue plasminogen activator (tPA) in methamphetamine (METH)-induced dopaminergic neurotoxicity, we compared the changes in tyrosine hydroxylase (TH) and dopamine transporter (DAT) levels in the striatum after repetitive treatment of METH at 4 mg/kg among wild-type, tPA-deficient (tPA−/−), and protease activated receptor-1-deficient (PAR-1−/−) mice. METH treatment caused a marked decrease in TH and DAT levels in the striatum of those mice with a similar magnitude. No difference in METH-induced abnormal behavior and hyperthermia was observed among the three types of mice. These results suggest that neither tPA nor PAR-1 is involved in METH-induced dopaminergic neurotoxicity in vivo. Keywords:: methamphetamine, neurotoxicity, tissue plasminogen activator 
546 |a EN 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Journal of Pharmacological Sciences, Vol 106, Iss 2, Pp 321-324 (2008) 
787 0 |n http://www.sciencedirect.com/science/article/pii/S1347861319340964 
787 0 |n https://doaj.org/toc/1347-8613 
856 4 1 |u https://doaj.org/article/abd51f5e1b8c4e788cf5586c88627e02  |z Connect to this object online.